The SafeSEQ HPV Test is a clinical grade, ultra-sensitive liquid biopsy solution for the identification and quantification of circulating HPV 16 and HPV 18 DNA in patients with cancers caused by HPV infection, including cervical cancer, anal squamous cell carcinoma, and head and neck squamous cell cancer. The SafeSEQ HPV Test detects HPV copies across a high dynamic range of levels, and demonstrates a high level of accuracy even when few copies are present, which enables high-resolution molecular monitoring.
HPV causes several different malignancies, including cervical cancer, anal squamous cell carcinoma, and head and neck squamous cell carcinoma. For example, HPV 16 causes the majority of oropharyngeal cancer in the United States1. HPV DNA detection in plasma using the SafeSEQ HPV Test enables precise tracking of disease burden and response to therapy in patients with HPV associated cancer.